Global Durvalumab Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Durvalumab Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Durvalumab by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Durvalumab by Country/Region, 2017, 2022 & 2028

2.2 Durvalumab Segment by Type

2.2.1 2.4mL Injection

2.2.2 10mL Injection

2.3 Durvalumab Sales by Type

2.3.1 Global Durvalumab Sales Market Share by Type (2017-2022)

2.3.2 Global Durvalumab Revenue and Market Share by Type (2017-2022)

2.3.3 Global Durvalumab Sale Price by Type (2017-2022)

2.4 Durvalumab Segment by Application

2.4.1 Locally Advanced Urothelial Carcinoma

2.4.2 Metastatic Urothelial Carcinoma

2.4.3 Other

2.5 Durvalumab Sales by Application

2.5.1 Global Durvalumab Sale Market Share by Application (2017-2022)

2.5.2 Global Durvalumab Revenue and Market Share by Application (2017-2022)

2.5.3 Global Durvalumab Sale Price by Application (2017-2022)

3 Global Durvalumab by Company

3.1 Global Durvalumab Breakdown Data by Company

3.1.1 Global Durvalumab Annual Sales by Company (2020-2022)

3.1.2 Global Durvalumab Sales Market Share by Company (2020-2022)

3.2 Global Durvalumab Annual Revenue by Company (2020-2022)

3.2.1 Global Durvalumab Revenue by Company (2020-2022)

3.2.2 Global Durvalumab Revenue Market Share by Company (2020-2022)

3.3 Global Durvalumab Sale Price by Company

3.4 Key Manufacturers Durvalumab Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Durvalumab Product Location Distribution

3.4.2 Players Durvalumab Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Durvalumab by Geographic Region

4.1 World Historic Durvalumab Market Size by Geographic Region (2017-2022)

4.1.1 Global Durvalumab Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Durvalumab Annual Revenue by Geographic Region

4.2 World Historic Durvalumab Market Size by Country/Region (2017-2022)

4.2.1 Global Durvalumab Annual Sales by Country/Region (2017-2022)

4.2.2 Global Durvalumab Annual Revenue by Country/Region

4.3 Americas Durvalumab Sales Growth

4.4 APAC Durvalumab Sales Growth

4.5 Europe Durvalumab Sales Growth

4.6 Middle East & Africa Durvalumab Sales Growth

5 Americas

5.1 Americas Durvalumab Sales by Country

5.1.1 Americas Durvalumab Sales by Country (2017-2022)

5.1.2 Americas Durvalumab Revenue by Country (2017-2022)

5.2 Americas Durvalumab Sales by Type

5.3 Americas Durvalumab Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Durvalumab Sales by Region

6.1.1 APAC Durvalumab Sales by Region (2017-2022)

6.1.2 APAC Durvalumab Revenue by Region (2017-2022)

6.2 APAC Durvalumab Sales by Type

6.3 APAC Durvalumab Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Durvalumab by Country

7.1.1 Europe Durvalumab Sales by Country (2017-2022)

7.1.2 Europe Durvalumab Revenue by Country (2017-2022)

7.2 Europe Durvalumab Sales by Type

7.3 Europe Durvalumab Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Durvalumab by Country

8.1.1 Middle East & Africa Durvalumab Sales by Country (2017-2022)

8.1.2 Middle East & Africa Durvalumab Revenue by Country (2017-2022)

8.2 Middle East & Africa Durvalumab Sales by Type

8.3 Middle East & Africa Durvalumab Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Durvalumab

10.3 Manufacturing Process Analysis of Durvalumab

10.4 Industry Chain Structure of Durvalumab

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Durvalumab Distributors

11.3 Durvalumab Customer

12 World Forecast Review for Durvalumab by Geographic Region

12.1 Global Durvalumab Market Size Forecast by Region

12.1.1 Global Durvalumab Forecast by Region (2023-2028)

12.1.2 Global Durvalumab Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Durvalumab Forecast by Type

12.7 Global Durvalumab Forecast by Application

13 Key Players Analysis

13.1 Medimmune (AstraZeneca)

13.1.1 Medimmune (AstraZeneca) Company Information

13.1.2 Medimmune (AstraZeneca) Durvalumab Product Offered

13.1.3 Medimmune (AstraZeneca) Durvalumab Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Medimmune (AstraZeneca) Main Business Overview

13.1.5 Medimmune (AstraZeneca) Latest Developments

14 Research Findings and Conclusion

Table 1. Durvalumab Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Durvalumab Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of 2.4mL Injection

Table 4. Major Players of 10mL Injection

Table 5. Global Durvalumab Sales by Type (2017-2022) & (K Pcs)

Table 6. Global Durvalumab Sales Market Share by Type (2017-2022)

Table 7. Global Durvalumab Revenue by Type (2017-2022) & ($ million)

Table 8. Global Durvalumab Revenue Market Share by Type (2017-2022)

Table 9. Global Durvalumab Sale Price by Type (2017-2022) & (USD/Pcs)

Table 10. Global Durvalumab Sales by Application (2017-2022) & (K Pcs)

Table 11. Global Durvalumab Sales Market Share by Application (2017-2022)

Table 12. Global Durvalumab Revenue by Application (2017-2022)

Table 13. Global Durvalumab Revenue Market Share by Application (2017-2022)

Table 14. Global Durvalumab Sale Price by Application (2017-2022) & (USD/Pcs)

Table 15. Global Durvalumab Sales by Company (2020-2022) & (K Pcs)

Table 16. Global Durvalumab Sales Market Share by Company (2020-2022)

Table 17. Global Durvalumab Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Durvalumab Revenue Market Share by Company (2020-2022)

Table 19. Global Durvalumab Sale Price by Company (2020-2022) & (USD/Pcs)

Table 20. Key Manufacturers Durvalumab Producing Area Distribution and Sales Area

Table 21. Players Durvalumab Products Offered

Table 22. Durvalumab Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Durvalumab Sales by Geographic Region (2017-2022) & (K Pcs)

Table 26. Global Durvalumab Sales Market Share Geographic Region (2017-2022)

Table 27. Global Durvalumab Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Durvalumab Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Durvalumab Sales by Country/Region (2017-2022) & (K Pcs)

Table 30. Global Durvalumab Sales Market Share by Country/Region (2017-2022)

Table 31. Global Durvalumab Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Durvalumab Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Durvalumab Sales by Country (2017-2022) & (K Pcs)

Table 34. Americas Durvalumab Sales Market Share by Country (2017-2022)

Table 35. Americas Durvalumab Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Durvalumab Revenue Market Share by Country (2017-2022)

Table 37. Americas Durvalumab Sales by Type (2017-2022) & (K Pcs)

Table 38. Americas Durvalumab Sales Market Share by Type (2017-2022)

Table 39. Americas Durvalumab Sales by Application (2017-2022) & (K Pcs)

Table 40. Americas Durvalumab Sales Market Share by Application (2017-2022)

Table 41. APAC Durvalumab Sales by Region (2017-2022) & (K Pcs)

Table 42. APAC Durvalumab Sales Market Share by Region (2017-2022)

Table 43. APAC Durvalumab Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Durvalumab Revenue Market Share by Region (2017-2022)

Table 45. APAC Durvalumab Sales by Type (2017-2022) & (K Pcs)

Table 46. APAC Durvalumab Sales Market Share by Type (2017-2022)

Table 47. APAC Durvalumab Sales by Application (2017-2022) & (K Pcs)

Table 48. APAC Durvalumab Sales Market Share by Application (2017-2022)

Table 49. Europe Durvalumab Sales by Country (2017-2022) & (K Pcs)

Table 50. Europe Durvalumab Sales Market Share by Country (2017-2022)

Table 51. Europe Durvalumab Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Durvalumab Revenue Market Share by Country (2017-2022)

Table 53. Europe Durvalumab Sales by Type (2017-2022) & (K Pcs)

Table 54. Europe Durvalumab Sales Market Share by Type (2017-2022)

Table 55. Europe Durvalumab Sales by Application (2017-2022) & (K Pcs)

Table 56. Europe Durvalumab Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Durvalumab Sales by Country (2017-2022) & (K Pcs)

Table 58. Middle East & Africa Durvalumab Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Durvalumab Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Durvalumab Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Durvalumab Sales by Type (2017-2022) & (K Pcs)

Table 62. Middle East & Africa Durvalumab Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Durvalumab Sales by Application (2017-2022) & (K Pcs)

Table 64. Middle East & Africa Durvalumab Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Durvalumab

Table 66. Key Market Challenges & Risks of Durvalumab

Table 67. Key Industry Trends of Durvalumab

Table 68. Durvalumab Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Durvalumab Distributors List

Table 71. Durvalumab Customer List

Table 72. Global Durvalumab Sales Forecast by Region (2023-2028) & (K Pcs)

Table 73. Global Durvalumab Sales Market Forecast by Region

Table 74. Global Durvalumab Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Durvalumab Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Durvalumab Sales Forecast by Country (2023-2028) & (K Pcs)

Table 77. Americas Durvalumab Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Durvalumab Sales Forecast by Region (2023-2028) & (K Pcs)

Table 79. APAC Durvalumab Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Durvalumab Sales Forecast by Country (2023-2028) & (K Pcs)

Table 81. Europe Durvalumab Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Durvalumab Sales Forecast by Country (2023-2028) & (K Pcs)

Table 83. Middle East & Africa Durvalumab Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Durvalumab Sales Forecast by Type (2023-2028) & (K Pcs)

Table 85. Global Durvalumab Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Durvalumab Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Durvalumab Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Durvalumab Sales Forecast by Application (2023-2028) & (K Pcs)

Table 89. Global Durvalumab Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Durvalumab Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Durvalumab Revenue Market Share Forecast by Application (2023-2028)

Table 92. Medimmune (AstraZeneca) Basic Information, Durvalumab Manufacturing Base, Sales Area and Its Competitors

Table 93. Medimmune (AstraZeneca) Durvalumab Product Offered

Table 94. Medimmune (AstraZeneca) Durvalumab Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 95. Medimmune (AstraZeneca) Main Business

Table 96. Medimmune (AstraZeneca) Latest Developments

List of Figures

Figure 1. Picture of Durvalumab

Figure 2. Durvalumab Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Durvalumab Sales Growth Rate 2017-2028 (K Pcs)

Figure 7. Global Durvalumab Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Durvalumab Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of 2.4mL Injection

Figure 10. Product Picture of 10mL Injection

Figure 11. Global Durvalumab Sales Market Share by Type in 2021

Figure 12. Global Durvalumab Revenue Market Share by Type (2017-2022)

Figure 13. Durvalumab Consumed in Locally Advanced Urothelial Carcinoma

Figure 14. Global Durvalumab Market: Locally Advanced Urothelial Carcinoma (2017-2022) & (K Pcs)

Figure 15. Durvalumab Consumed in Metastatic Urothelial Carcinoma

Figure 16. Global Durvalumab Market: Metastatic Urothelial Carcinoma (2017-2022) & (K Pcs)

Figure 17. Durvalumab Consumed in Other

Figure 18. Global Durvalumab Market: Other (2017-2022) & (K Pcs)

Figure 19. Global Durvalumab Sales Market Share by Application (2017-2022)

Figure 20. Global Durvalumab Revenue Market Share by Application in 2021

Figure 21. Durvalumab Revenue Market by Company in 2021 ($ Million)

Figure 22. Global Durvalumab Revenue Market Share by Company in 2021

Figure 23. Global Durvalumab Sales Market Share by Geographic Region (2017-2022)

Figure 24. Global Durvalumab Revenue Market Share by Geographic Region in 2021

Figure 25. Global Durvalumab Sales Market Share by Region (2017-2022)

Figure 26. Global Durvalumab Revenue Market Share by Country/Region in 2021

Figure 27. Americas Durvalumab Sales 2017-2022 (K Pcs)

Figure 28. Americas Durvalumab Revenue 2017-2022 ($ Millions)

Figure 29. APAC Durvalumab Sales 2017-2022 (K Pcs)

Figure 30. APAC Durvalumab Revenue 2017-2022 ($ Millions)

Figure 31. Europe Durvalumab Sales 2017-2022 (K Pcs)

Figure 32. Europe Durvalumab Revenue 2017-2022 ($ Millions)

Figure 33. Middle East & Africa Durvalumab Sales 2017-2022 (K Pcs)

Figure 34. Middle East & Africa Durvalumab Revenue 2017-2022 ($ Millions)

Figure 35. Americas Durvalumab Sales Market Share by Country in 2021

Figure 36. Americas Durvalumab Revenue Market Share by Country in 2021

Figure 37. United States Durvalumab Revenue Growth 2017-2022 ($ Millions)

Figure 38. Canada Durvalumab Revenue Growth 2017-2022 ($ Millions)

Figure 39. Mexico Durvalumab Revenue Growth 2017-2022 ($ Millions)

Figure 40. Brazil Durvalumab Revenue Growth 2017-2022 ($ Millions)

Figure 41. APAC Durvalumab Sales Market Share by Region in 2021

Figure 42. APAC Durvalumab Revenue Market Share by Regions in 2021

Figure 43. China Durvalumab Revenue Growth 2017-2022 ($ Millions)

Figure 44. Japan Durvalumab Revenue Growth 2017-2022 ($ Millions)

Figure 45. South Korea Durvalumab Revenue Growth 2017-2022 ($ Millions)

Figure 46. Southeast Asia Durvalumab Revenue Growth 2017-2022 ($ Millions)

Figure 47. India Durvalumab Revenue Growth 2017-2022 ($ Millions)

Figure 48. Australia Durvalumab Revenue Growth 2017-2022 ($ Millions)

Figure 49. Europe Durvalumab Sales Market Share by Country in 2021

Figure 50. Europe Durvalumab Revenue Market Share by Country in 2021

Figure 51. Germany Durvalumab Revenue Growth 2017-2022 ($ Millions)

Figure 52. France Durvalumab Revenue Growth 2017-2022 ($ Millions)

Figure 53. UK Durvalumab Revenue Growth 2017-2022 ($ Millions)

Figure 54. Italy Durvalumab Revenue Growth 2017-2022 ($ Millions)

Figure 55. Russia Durvalumab Revenue Growth 2017-2022 ($ Millions)

Figure 56. Middle East & Africa Durvalumab Sales Market Share by Country in 2021

Figure 57. Middle East & Africa Durvalumab Revenue Market Share by Country in 2021

Figure 58. Egypt Durvalumab Revenue Growth 2017-2022 ($ Millions)

Figure 59. South Africa Durvalumab Revenue Growth 2017-2022 ($ Millions)

Figure 60. Israel Durvalumab Revenue Growth 2017-2022 ($ Millions)

Figure 61. Turkey Durvalumab Revenue Growth 2017-2022 ($ Millions)

Figure 62. GCC Country Durvalumab Revenue Growth 2017-2022 ($ Millions)

Figure 63. Manufacturing Cost Structure Analysis of Durvalumab in 2021

Figure 64. Manufacturing Process Analysis of Durvalumab

Figure 65. Industry Chain Structure of Durvalumab

Figure 66. Channels of Distribution

Figure 67. Distributors Profiles